Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia

BackgroundThe incidence and nature of excessive weight gain associated with antiretroviral treatment using tenofovir, lamivudine, and dolutegravir based regimens among patients living with human immunodeficiency virus has not been properly examined in Ethiopia. Therefore, this study aimed to assess...

Descripció completa

Dades bibliogràfiques

Autors principals:	Gashaw Sisay Chanie, Wagaye Atalay, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Yonas Sisay Aragie, Gizachew Kassahun Bizuneh, Mihret Melese, Rahel Belete Abebe
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-04-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	excessive weight gain tenofovir lamivudine and dolutegravir PLHIV
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1394458/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!